 |
 |
|
|
|
| Flunixin meglumine |
 |
| 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt; 1-Deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate |
 |
| 42461-84-7 |
 |
| Because it targets the inflamed tissue, flunixin is mainly used for colic pain, muscle pain, and joint disease, as well as to alleviate fevers and pain, and prevent endotoxemia. It is also effective in injuries of the eye.The full analgesic and antipyretic effects usually occur 1-2 hours following treatment, but there is often an effective analgesic effect within approximately 15 minutes. |
 |
Flunixin meglumine
Identification
Name Flunixin meglumin
Synonyms 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt
1-Deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate
Molecular Formula C14H11F3N2O2.C7H17NO5
Molecular Weight 491.46
CAS Registry Number 42461-84-7
EINECS 255-836-0
Melting point 136-138 ºC
Water solubility soluble
Uses: Because it targets the inflamed tissue, flunixin is mainly used for colic pain, muscle pain, and joint disease, as well as to alleviate fevers and pain, and prevent endotoxemia. It is also effective in injuries of the eye.The full analgesic and antipyretic effects usually occur 1-2 hours following treatment, but there is often an effective analgesic effect within approximately 15 minutes. |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
